Lilly, Bristol-Myers Squibb Stop Enrollment In One Of Two Phase III Lung Cancer Trial

		Cancer Friends Network > Types of Cancer > Lung Cancer
Lilly, Bristol-Myers Squibb Stop Enrollment In One Of Two Phase III Lung Cancer Trial

LinkBack

Thread Tools

Display Modes

#1 (permalink)

02-09-2011, 06:14 PM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,390

Lilly, Bristol-Myers Squibb Stop Enrollment In One Of Two Phase III Lung Cancer Trial

Eli Lilly and Company (NYSE: LLY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that they have stopped enrollment in one of their two global Phase III studies evaluating necitumumab, an investigational anti-cancer agent, as a first-line treatment for advanced non-small cell lung cancer (NSCLC).

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 07:53 PM.

CancerFriends.net